News and Comments

ILMN AND HGSI: REASONS FOR ATYPICAL REJECTIONS OF TAKEOVERS

  Sunday, April 22, 2012

These days all the focus, the talk, the debates, and the confusion are, and will certainly continue for a while to be, about Illumina’s (ILMN) and Human Genome’s (HGSI) rejection of the acquisitions offers. The truth is that the offers were not as generous as they are said they are. More...

AFFYMAX vs. AMGEN?

  Tuesday, April 03, 2012

Affymax (AFFY) red blood growth factor drug Omontys (peginesatide) was granted FDA approval – good news for the firm. The approval is a remarkable achievement by Affymax. The firm has proven a capability developing biological products and there is no doubt that AFFY will sell the drug Omontys for patients with chronic kidney disease on dialysis, as it is dictated by the FDA.  More...


Recent Postings


Archive


Tags

Aimmune Therapeutics (AIMT) galapagos (GLPG) AstraZeneca (AZN) Sequenom (SQNM) Intrexon (XON) ZALTRAP™ Anadys (ANDS) Cytokinetics (CYTK) Ocular Therapeutix (OCUL) Spike Therapeutics (ONCE) SYNTA (SNTA) Human Genome Sciences (HGSI) Prolor Biotech (PBTH) ADVENTRIX (ANX) Regeneron (REGN) ARCA (ABIO) Intermune (ITMN) HALOZYME (HALO) Array Pharmaceuticals (ARRY) JUNO (JUNO) ImmunoGen (IMGN) KERYX (KERX) Bellicum (BLCM) Onyx (ONXX) Vitae Pharmaceuticals (VTAE) Velcade (bortezomib) Biocryst (BCRX) Theravance (THRX) SERES THERAPEUTICS (MCRB) RenenxBio (RGNX) Exelixis (EXEL) AERIE PHARMACEUTICALS Benlysta (belimumab) Editas (EDIT) Jazz Pharmaceuticals (JAZZ) Multiple Myeloma REGULUS (RGLS) Sanofi (SNY) Telaprevir Sanofi (SNA) Ziofpharm (ZIOP) Bristol-Myers Squibb (BMY) C4 Therapeutics PTC Therapeutics (PTCT) Agenus (AGEN Ridaforolimus ARGOS (ARGS) ACADIA (ACAD) Anacor (ANAC) Rapamune Biogen Idec (BIIB) Sanofi-Aventis (SAN) CompuGen (CGEN) IDERA (IDRA) Valeant Pharmaceuticals International (VRX) Human Longevity (HLI) Dendreon (DNDN) Prosensa (RNA) INNOVIVA (INVA) Pluristem (PSTI) Auspex (ASPX) NEKTAR (NKTR)) Zerenex Intercept (ICPT) Agenus (AGEN) VANDA (VNDA) ISIS (ISIS) Roche (RHHBY) Alder Biopharmaceuticals (ALDR) Inovio (INO) ABBVIE (ABBV) OSI (OSIP) Adaptimmune (ADAP) Revlimid (lenolidamide) Global Cell Therapeutics (GBT) Sangamo (SGMO) Xoma (XOMA) Micromet (MITI) Amgen (AMGN) Ionis (IONS) Elan (ELN) Alnylam (ALNY) Illumina (ILMN) CRISPR Therapeutics (CRSP) Merck (MRK) Incyte (INCY) Herceptin SUNESIS PHARMACEUTICALS (SNSS) Galena (GALE) Vertex (VRTX) Dynavax (DVAX) Genentech MODERNA GlaxoSmithKline (GSK) Roche (ROCHE) Gilead (GILD) Endometrial Cancer AGOS (ARGS) Sarepta (SRPT) Advaxis (ADXS) NANTKWEST (NK) GUARDIAN HEALTH Tysabri BIOMARIN (BMRN) NOVOCURE (NVCR) Theravance Bio Pharma (TBPH) KITE (KITE) Trastuzumab-DM1 TOKAI (TKAOI) Idenix (IDIX) Ariad (ARIA) Abbott Laboratories (ABT) CEMPRA (CEMP) Mirati Therapeutics (MRTX) Seattle Genetics (SGEN)